AKR1B1
Aldo-keto reductase family 1 member B1
Also known as: ALDR_HUMAN, ALDR1, AR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15121
- Gene
- AKR1B1
- Ensembl
- ENSG00000085662
- Chromosome
- 7
- Canonical length
- 316 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member catalyzes the reduction of a number of aldehydes, including the aldehyde form of glucose, and is thereby implicated in the development of diabetic complications by catalyzing the reduction of glucose to sorbitol. Multiple pseudogenes have been identified for this gene. The nomenclature system used by the HUGO Gene Nomenclature Committee to define human aldo-keto reductase family members is known to differ from that used by the Mouse Genome Informatics database. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
316 residues, UniProt reviewed canonical sequence.
>P15121|AKR1B1
1 MASRLLLNNG AKMPILGLGT WKSPPGQVTE AVKVAIDVGY RHIDCAHVYQ NENEVGVAIQ
61 EKLREQVVKR EELFIVSKLW CTYHEKGLVK GACQKTLSDL KLDYLDLYLI HWPTGFKPGK
121 EFFPLDESGN VVPSDTNILD TWAAMEELVD EGLVKAIGIS NFNHLQVEMI LNKPGLKYKP
181 AVNQIECHPY LTQEKLIQYC QSKGIVVTAY SPLGSPDRPW AKPEDPSLLE DPRIKAIAAK
241 HNKTTAQVLI RFPMQRNLVV IPKSVTPERI AENFKVFDFE LSSQDMTTLL SYNRNWRVCA
301 LLSCTSHKDY PFHEEFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AKR1B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 3,017 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 3,017 nTPM
- kidney: 403 nTPM
- tongue: 371 nTPM
- seminal vesicle: 314 nTPM
- skeletal muscle: 309 nTPM
- heart muscle: 202 nTPM
Single-cell type
- syncytiotrophoblasts: 2,451 nCPM
- migrating cytotrophoblasts: 1,521 nCPM
- extravillous trophoblasts: 1,457 nCPM
- cytotrophoblasts: 1,274 nCPM
- adrenal cortex cells: 910 nCPM
- oocytes: 686 nCPM
Immune cell
- total PBMC: 230 nTPM
- naive CD4 T-cell: 163 nTPM
- naive CD8 T-cell: 157 nTPM
- gdT-cell: 148 nTPM
- myeloid DC: 145 nTPM
- memory CD8 T-cell: 145 nTPM
Brain region
- pons: 103 nTPM
- medulla oblongata: 96 nTPM
- white matter: 95 nTPM
- midbrain: 87 nTPM
- hypothalamus: 77 nTPM
- spinal cord: 74 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- C21-steroid hormone biosynthetic process
- carbohydrate metabolic process
- cellular hyperosmotic salinity response
- daunorubicin metabolic process
- doxorubicin metabolic process
- epithelial cell maturation
- fructose biosynthetic process
- metanephric collecting duct development
- negative regulation of apoptotic process
- regulation of urine volume
- renal water homeostasis
- retinoid metabolic process
Molecular functions
- aldose reductase (NADPH) activity
- all-trans-retinol dehydrogenase (NADP+) activity
- allyl-alcohol dehydrogenase activity
- electron transfer activity
- glycerol dehydrogenase (NADP+) activity
- L-glucuronate reductase activity
- prostaglandin H2 endoperoxidase reductase activity
- retinal dehydrogenase (NAD+) activity
- glyceraldehyde oxidoreductase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AKR1B1 as an antibody target. Whether an autoantibody or antibody against AKR1B1 could matter depends on whether native AKR1B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AKR1B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AKR1B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...